nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—Temperature intolerance—Levothyroxine—hypothyroidism	0.0214	0.0731	CcSEcCtD
Dasatinib—Temperature intolerance—Dextrothyroxine—hypothyroidism	0.0214	0.0731	CcSEcCtD
Dasatinib—ABCB1—Levothyroxine—hypothyroidism	0.0183	0.28	CbGbCtD
Dasatinib—ABCB1—Liothyronine—hypothyroidism	0.0183	0.28	CbGbCtD
Dasatinib—ABCB1—Liotrix—hypothyroidism	0.0179	0.273	CbGbCtD
Dasatinib—Temperature intolerance—Liotrix—hypothyroidism	0.0157	0.0537	CcSEcCtD
Dasatinib—CYP3A4—Levothyroxine—hypothyroidism	0.011	0.168	CbGbCtD
Dasatinib—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00633	0.0217	CcSEcCtD
Dasatinib—Menstruation irregular—Levothyroxine—hypothyroidism	0.00633	0.0217	CcSEcCtD
Dasatinib—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00572	0.0195	CcSEcCtD
Dasatinib—Swelling face—Liotrix—hypothyroidism	0.00542	0.0185	CcSEcCtD
Dasatinib—Menstruation irregular—Liotrix—hypothyroidism	0.00466	0.0159	CcSEcCtD
Dasatinib—Angina pectoris—Liothyronine—hypothyroidism	0.00436	0.0149	CcSEcCtD
Dasatinib—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00394	0.0135	CcSEcCtD
Dasatinib—Myocardial infarction—Liothyronine—hypothyroidism	0.00392	0.0134	CcSEcCtD
Dasatinib—Coagulopathy—Liotrix—hypothyroidism	0.00331	0.0113	CcSEcCtD
Dasatinib—Arrhythmia—Liothyronine—hypothyroidism	0.0032	0.011	CcSEcCtD
Dasatinib—Hypocalcaemia—Liotrix—hypothyroidism	0.00282	0.00964	CcSEcCtD
Dasatinib—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00281	0.0096	CcSEcCtD
Dasatinib—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00281	0.0096	CcSEcCtD
Dasatinib—Creatinine increased—Liotrix—hypothyroidism	0.00271	0.00927	CcSEcCtD
Dasatinib—Hypertension—Liothyronine—hypothyroidism	0.00269	0.00922	CcSEcCtD
Dasatinib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00261	0.00892	CcSEcCtD
Dasatinib—Cardiac failure—Levothyroxine—hypothyroidism	0.00261	0.00892	CcSEcCtD
Dasatinib—Affect lability—Levothyroxine—hypothyroidism	0.00251	0.00857	CcSEcCtD
Dasatinib—Affect lability—Dextrothyroxine—hypothyroidism	0.00251	0.00857	CcSEcCtD
Dasatinib—Tachycardia—Liothyronine—hypothyroidism	0.00249	0.0085	CcSEcCtD
Dasatinib—Fluid retention—Liotrix—hypothyroidism	0.00245	0.00837	CcSEcCtD
Dasatinib—Hypotension—Liothyronine—hypothyroidism	0.00238	0.00814	CcSEcCtD
Dasatinib—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00224	0.00768	CcSEcCtD
Dasatinib—Muscular weakness—Levothyroxine—hypothyroidism	0.00224	0.00768	CcSEcCtD
Dasatinib—Sepsis—Liotrix—hypothyroidism	0.00224	0.00765	CcSEcCtD
Dasatinib—Dysphagia—Dextrothyroxine—hypothyroidism	0.0022	0.00752	CcSEcCtD
Dasatinib—Dysphagia—Levothyroxine—hypothyroidism	0.0022	0.00752	CcSEcCtD
Dasatinib—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00214	0.00733	CcSEcCtD
Dasatinib—Angina pectoris—Levothyroxine—hypothyroidism	0.00214	0.00733	CcSEcCtD
Dasatinib—Cardiac failure congestive—Liotrix—hypothyroidism	0.00206	0.00706	CcSEcCtD
Dasatinib—Body temperature increased—Liothyronine—hypothyroidism	0.00201	0.00689	CcSEcCtD
Dasatinib—Weight decreased—Levothyroxine—hypothyroidism	0.00199	0.00681	CcSEcCtD
Dasatinib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00199	0.00681	CcSEcCtD
Dasatinib—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00193	0.00661	CcSEcCtD
Dasatinib—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00193	0.00661	CcSEcCtD
Dasatinib—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00192	0.00658	CcSEcCtD
Dasatinib—Myocardial infarction—Levothyroxine—hypothyroidism	0.00192	0.00658	CcSEcCtD
Dasatinib—Cardiac failure—Liotrix—hypothyroidism	0.00192	0.00656	CcSEcCtD
Dasatinib—Cerebrovascular accident—Liotrix—hypothyroidism	0.00191	0.00653	CcSEcCtD
Dasatinib—Affect lability—Liotrix—hypothyroidism	0.00184	0.0063	CcSEcCtD
Dasatinib—Blood creatinine increased—Liotrix—hypothyroidism	0.00175	0.006	CcSEcCtD
Dasatinib—Hypokalaemia—Liotrix—hypothyroidism	0.0017	0.00583	CcSEcCtD
Dasatinib—Muscular weakness—Liotrix—hypothyroidism	0.00165	0.00565	CcSEcCtD
Dasatinib—Flushing—Dextrothyroxine—hypothyroidism	0.00163	0.00559	CcSEcCtD
Dasatinib—Flushing—Levothyroxine—hypothyroidism	0.00163	0.00559	CcSEcCtD
Dasatinib—Abdominal distension—Liotrix—hypothyroidism	0.00163	0.00557	CcSEcCtD
Dasatinib—Dysphagia—Liotrix—hypothyroidism	0.00162	0.00553	CcSEcCtD
Dasatinib—Bronchospasm—Liotrix—hypothyroidism	0.00159	0.00544	CcSEcCtD
Dasatinib—Angina pectoris—Liotrix—hypothyroidism	0.00158	0.00539	CcSEcCtD
Dasatinib—Arrhythmia—Levothyroxine—hypothyroidism	0.00157	0.00538	CcSEcCtD
Dasatinib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00157	0.00538	CcSEcCtD
Dasatinib—Alopecia—Levothyroxine—hypothyroidism	0.00156	0.00532	CcSEcCtD
Dasatinib—Alopecia—Dextrothyroxine—hypothyroidism	0.00156	0.00532	CcSEcCtD
Dasatinib—Weight decreased—Liotrix—hypothyroidism	0.00146	0.00501	CcSEcCtD
Dasatinib—Tremor—Dextrothyroxine—hypothyroidism	0.00144	0.00491	CcSEcCtD
Dasatinib—Tremor—Levothyroxine—hypothyroidism	0.00144	0.00491	CcSEcCtD
Dasatinib—Acute coronary syndrome—Liotrix—hypothyroidism	0.00142	0.00486	CcSEcCtD
Dasatinib—Renal failure—Liotrix—hypothyroidism	0.00142	0.00485	CcSEcCtD
Dasatinib—Myocardial infarction—Liotrix—hypothyroidism	0.00141	0.00484	CcSEcCtD
Dasatinib—Palpitations—Dextrothyroxine—hypothyroidism	0.00135	0.00463	CcSEcCtD
Dasatinib—Palpitations—Levothyroxine—hypothyroidism	0.00135	0.00463	CcSEcCtD
Dasatinib—Convulsion—Levothyroxine—hypothyroidism	0.00133	0.00454	CcSEcCtD
Dasatinib—Convulsion—Dextrothyroxine—hypothyroidism	0.00133	0.00454	CcSEcCtD
Dasatinib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00131	0.00446	CcSEcCtD
Dasatinib—Arthralgia—Levothyroxine—hypothyroidism	0.00131	0.00446	CcSEcCtD
Dasatinib—Anxiety—Levothyroxine—hypothyroidism	0.0013	0.00445	CcSEcCtD
Dasatinib—Anxiety—Dextrothyroxine—hypothyroidism	0.0013	0.00445	CcSEcCtD
Dasatinib—Confusional state—Dextrothyroxine—hypothyroidism	0.00126	0.00431	CcSEcCtD
Dasatinib—Confusional state—Levothyroxine—hypothyroidism	0.00126	0.00431	CcSEcCtD
Dasatinib—Shock—Levothyroxine—hypothyroidism	0.00123	0.00421	CcSEcCtD
Dasatinib—Shock—Dextrothyroxine—hypothyroidism	0.00123	0.00421	CcSEcCtD
Dasatinib—Tachycardia—Levothyroxine—hypothyroidism	0.00122	0.00418	CcSEcCtD
Dasatinib—Tachycardia—Dextrothyroxine—hypothyroidism	0.00122	0.00418	CcSEcCtD
Dasatinib—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00121	0.00414	CcSEcCtD
Dasatinib—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00121	0.00414	CcSEcCtD
Dasatinib—Flushing—Liotrix—hypothyroidism	0.0012	0.00411	CcSEcCtD
Dasatinib—Arrhythmia—Liotrix—hypothyroidism	0.00116	0.00396	CcSEcCtD
Dasatinib—Alopecia—Liotrix—hypothyroidism	0.00114	0.00391	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00114	0.0039	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00114	0.0039	CcSEcCtD
Dasatinib—Insomnia—Levothyroxine—hypothyroidism	0.00113	0.00387	CcSEcCtD
Dasatinib—Insomnia—Dextrothyroxine—hypothyroidism	0.00113	0.00387	CcSEcCtD
Dasatinib—Dyspnoea—Levothyroxine—hypothyroidism	0.00112	0.00381	CcSEcCtD
Dasatinib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00112	0.00381	CcSEcCtD
Dasatinib—Dysgeusia—Liotrix—hypothyroidism	0.0011	0.00378	CcSEcCtD
Dasatinib—Fatigue—Levothyroxine—hypothyroidism	0.00108	0.00369	CcSEcCtD
Dasatinib—Fatigue—Dextrothyroxine—hypothyroidism	0.00108	0.00369	CcSEcCtD
Dasatinib—Vision blurred—Liotrix—hypothyroidism	0.00106	0.00363	CcSEcCtD
Dasatinib—Tremor—Liotrix—hypothyroidism	0.00106	0.00361	CcSEcCtD
Dasatinib—Feeling abnormal—Levothyroxine—hypothyroidism	0.00103	0.00353	CcSEcCtD
Dasatinib—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00103	0.00353	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00102	0.0035	CcSEcCtD
Dasatinib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00102	0.0035	CcSEcCtD
Dasatinib—Syncope—Liotrix—hypothyroidism	0.00101	0.00346	CcSEcCtD
Dasatinib—Palpitations—Liotrix—hypothyroidism	0.000996	0.00341	CcSEcCtD
Dasatinib—Urticaria—Levothyroxine—hypothyroidism	0.000994	0.0034	CcSEcCtD
Dasatinib—Urticaria—Dextrothyroxine—hypothyroidism	0.000994	0.0034	CcSEcCtD
Dasatinib—Loss of consciousness—Liotrix—hypothyroidism	0.000991	0.00339	CcSEcCtD
Dasatinib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000989	0.00338	CcSEcCtD
Dasatinib—Abdominal pain—Levothyroxine—hypothyroidism	0.000989	0.00338	CcSEcCtD
Dasatinib—Body temperature increased—Levothyroxine—hypothyroidism	0.000989	0.00338	CcSEcCtD
Dasatinib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000989	0.00338	CcSEcCtD
Dasatinib—Convulsion—Liotrix—hypothyroidism	0.000977	0.00334	CcSEcCtD
Dasatinib—Hypertension—Liotrix—hypothyroidism	0.000974	0.00333	CcSEcCtD
Dasatinib—Arthralgia—Liotrix—hypothyroidism	0.00096	0.00328	CcSEcCtD
Dasatinib—Chest pain—Liotrix—hypothyroidism	0.00096	0.00328	CcSEcCtD
Dasatinib—Anxiety—Liotrix—hypothyroidism	0.000957	0.00327	CcSEcCtD
Dasatinib—Confusional state—Liotrix—hypothyroidism	0.000928	0.00317	CcSEcCtD
Dasatinib—Oedema—Liotrix—hypothyroidism	0.00092	0.00315	CcSEcCtD
Dasatinib—Infection—Liotrix—hypothyroidism	0.000914	0.00313	CcSEcCtD
Dasatinib—Shock—Liotrix—hypothyroidism	0.000905	0.0031	CcSEcCtD
Dasatinib—Tachycardia—Liotrix—hypothyroidism	0.000898	0.00307	CcSEcCtD
Dasatinib—Asthenia—Levothyroxine—hypothyroidism	0.000898	0.00307	CcSEcCtD
Dasatinib—Asthenia—Dextrothyroxine—hypothyroidism	0.000898	0.00307	CcSEcCtD
Dasatinib—Hyperhidrosis—Liotrix—hypothyroidism	0.00089	0.00304	CcSEcCtD
Dasatinib—Pruritus—Dextrothyroxine—hypothyroidism	0.000885	0.00303	CcSEcCtD
Dasatinib—Pruritus—Levothyroxine—hypothyroidism	0.000885	0.00303	CcSEcCtD
Dasatinib—Anorexia—Liotrix—hypothyroidism	0.000877	0.003	CcSEcCtD
Dasatinib—Hypotension—Liotrix—hypothyroidism	0.00086	0.00294	CcSEcCtD
Dasatinib—Diarrhoea—Levothyroxine—hypothyroidism	0.000856	0.00293	CcSEcCtD
Dasatinib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000856	0.00293	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000838	0.00287	CcSEcCtD
Dasatinib—Insomnia—Liotrix—hypothyroidism	0.000832	0.00285	CcSEcCtD
Dasatinib—Dyspnoea—Liotrix—hypothyroidism	0.00082	0.00281	CcSEcCtD
Dasatinib—Decreased appetite—Liotrix—hypothyroidism	0.0008	0.00274	CcSEcCtD
Dasatinib—Vomiting—Levothyroxine—hypothyroidism	0.000795	0.00272	CcSEcCtD
Dasatinib—Vomiting—Dextrothyroxine—hypothyroidism	0.000795	0.00272	CcSEcCtD
Dasatinib—Fatigue—Liotrix—hypothyroidism	0.000793	0.00271	CcSEcCtD
Dasatinib—Rash—Dextrothyroxine—hypothyroidism	0.000789	0.0027	CcSEcCtD
Dasatinib—Rash—Levothyroxine—hypothyroidism	0.000789	0.0027	CcSEcCtD
Dasatinib—Dermatitis—Levothyroxine—hypothyroidism	0.000788	0.0027	CcSEcCtD
Dasatinib—Dermatitis—Dextrothyroxine—hypothyroidism	0.000788	0.0027	CcSEcCtD
Dasatinib—Constipation—Liotrix—hypothyroidism	0.000787	0.00269	CcSEcCtD
Dasatinib—Headache—Levothyroxine—hypothyroidism	0.000784	0.00268	CcSEcCtD
Dasatinib—Headache—Dextrothyroxine—hypothyroidism	0.000784	0.00268	CcSEcCtD
Dasatinib—Feeling abnormal—Liotrix—hypothyroidism	0.000758	0.00259	CcSEcCtD
Dasatinib—Gastrointestinal pain—Liotrix—hypothyroidism	0.000753	0.00257	CcSEcCtD
Dasatinib—Nausea—Dextrothyroxine—hypothyroidism	0.000743	0.00254	CcSEcCtD
Dasatinib—Nausea—Levothyroxine—hypothyroidism	0.000743	0.00254	CcSEcCtD
Dasatinib—Urticaria—Liotrix—hypothyroidism	0.000731	0.0025	CcSEcCtD
Dasatinib—Abdominal pain—Liotrix—hypothyroidism	0.000727	0.00249	CcSEcCtD
Dasatinib—Body temperature increased—Liotrix—hypothyroidism	0.000727	0.00249	CcSEcCtD
Dasatinib—JAK2—pituitary gland—hypothyroidism	0.000718	0.002	CbGeAlD
Dasatinib—EPHA4—thyroid gland—hypothyroidism	0.000713	0.00199	CbGeAlD
Dasatinib—RIPK2—female gonad—hypothyroidism	0.000713	0.00199	CbGeAlD
Dasatinib—EPHA2—pituitary gland—hypothyroidism	0.000709	0.00198	CbGeAlD
Dasatinib—MAP3K3—gonad—hypothyroidism	0.000709	0.00198	CbGeAlD
Dasatinib—MAP4K5—gonad—hypothyroidism	0.000709	0.00198	CbGeAlD
Dasatinib—FYN—pituitary gland—hypothyroidism	0.000708	0.00198	CbGeAlD
Dasatinib—PDGFRA—cardiovascular system—hypothyroidism	0.000708	0.00198	CbGeAlD
Dasatinib—LIMK2—testis—hypothyroidism	0.000708	0.00197	CbGeAlD
Dasatinib—ERBB3—thyroid gland—hypothyroidism	0.000706	0.00197	CbGeAlD
Dasatinib—TESK1—liver—hypothyroidism	0.000703	0.00196	CbGeAlD
Dasatinib—MAP2K5—adrenal cortex—hypothyroidism	0.0007	0.00195	CbGeAlD
Dasatinib—MAP3K2—thyroid gland—hypothyroidism	0.000699	0.00195	CbGeAlD
Dasatinib—SIK1—female gonad—hypothyroidism	0.000696	0.00194	CbGeAlD
Dasatinib—SRC—cardiovascular system—hypothyroidism	0.000694	0.00194	CbGeAlD
Dasatinib—MAP4K5—pituitary gland—hypothyroidism	0.000692	0.00193	CbGeAlD
Dasatinib—MAP3K3—pituitary gland—hypothyroidism	0.000692	0.00193	CbGeAlD
Dasatinib—STK36—liver—hypothyroidism	0.000692	0.00193	CbGeAlD
Dasatinib—EPHA4—female gonad—hypothyroidism	0.000689	0.00192	CbGeAlD
Dasatinib—TESK1—cerebellum—hypothyroidism	0.000687	0.00192	CbGeAlD
Dasatinib—STK35—testis—hypothyroidism	0.000686	0.00191	CbGeAlD
Dasatinib—CSF1R—adrenal cortex—hypothyroidism	0.000683	0.00191	CbGeAlD
Dasatinib—ERBB3—female gonad—hypothyroidism	0.000682	0.0019	CbGeAlD
Dasatinib—MAPK14—adrenal gland—hypothyroidism	0.000681	0.0019	CbGeAlD
Dasatinib—MAPK14—blood—hypothyroidism	0.000681	0.0019	CbGeAlD
Dasatinib—CSK—testis—hypothyroidism	0.000681	0.0019	CbGeAlD
Dasatinib—FGR—adrenal gland—hypothyroidism	0.000679	0.00189	CbGeAlD
Dasatinib—LCK—adrenal gland—hypothyroidism	0.000679	0.00189	CbGeAlD
Dasatinib—FGR—blood—hypothyroidism	0.000679	0.00189	CbGeAlD
Dasatinib—LCK—blood—hypothyroidism	0.000679	0.00189	CbGeAlD
Dasatinib—Hypersensitivity—Liotrix—hypothyroidism	0.000678	0.00232	CcSEcCtD
Dasatinib—MAP2K5—heart—hypothyroidism	0.000677	0.00189	CbGeAlD
Dasatinib—EPHB3—cerebellum—hypothyroidism	0.000676	0.00189	CbGeAlD
Dasatinib—STK36—cerebellum—hypothyroidism	0.000676	0.00189	CbGeAlD
Dasatinib—MAP3K2—female gonad—hypothyroidism	0.000676	0.00189	CbGeAlD
Dasatinib—HCK—testis—hypothyroidism	0.000673	0.00188	CbGeAlD
Dasatinib—LIMK2—liver—hypothyroidism	0.000669	0.00187	CbGeAlD
Dasatinib—ABL2—testis—hypothyroidism	0.000668	0.00186	CbGeAlD
Dasatinib—EPHB6—pituitary gland—hypothyroidism	0.000661	0.00184	CbGeAlD
Dasatinib—CSF1R—heart—hypothyroidism	0.000661	0.00184	CbGeAlD
Dasatinib—Asthenia—Liotrix—hypothyroidism	0.00066	0.00226	CcSEcCtD
Dasatinib—MAPK14—thyroid gland—hypothyroidism	0.000658	0.00183	CbGeAlD
Dasatinib—FMO3—adrenal gland—hypothyroidism	0.000656	0.00183	CbGeAlD
Dasatinib—YES1—gonad—hypothyroidism	0.000655	0.00183	CbGeAlD
Dasatinib—FGR—thyroid gland—hypothyroidism	0.000655	0.00183	CbGeAlD
Dasatinib—LCK—thyroid gland—hypothyroidism	0.000655	0.00183	CbGeAlD
Dasatinib—LIMK2—cerebellum—hypothyroidism	0.000653	0.00182	CbGeAlD
Dasatinib—Pruritus—Liotrix—hypothyroidism	0.000651	0.00223	CcSEcCtD
Dasatinib—STK35—liver—hypothyroidism	0.000648	0.00181	CbGeAlD
Dasatinib—EPHB4—adrenal gland—hypothyroidism	0.000646	0.0018	CbGeAlD
Dasatinib—EPHB4—blood—hypothyroidism	0.000646	0.0018	CbGeAlD
Dasatinib—CSK—liver—hypothyroidism	0.000644	0.0018	CbGeAlD
Dasatinib—PDGFRA—gonad—hypothyroidism	0.000643	0.00179	CbGeAlD
Dasatinib—JAK2—adrenal gland—hypothyroidism	0.000641	0.00179	CbGeAlD
Dasatinib—JAK2—blood—hypothyroidism	0.000641	0.00179	CbGeAlD
Dasatinib—YES1—pituitary gland—hypothyroidism	0.000639	0.00178	CbGeAlD
Dasatinib—MAP2K5—cardiovascular system—hypothyroidism	0.000639	0.00178	CbGeAlD
Dasatinib—HCK—liver—hypothyroidism	0.000636	0.00177	CbGeAlD
Dasatinib—MAPK14—female gonad—hypothyroidism	0.000635	0.00177	CbGeAlD
Dasatinib—EPHA2—adrenal gland—hypothyroidism	0.000634	0.00177	CbGeAlD
Dasatinib—EPHA2—blood—hypothyroidism	0.000634	0.00177	CbGeAlD
Dasatinib—STK35—cerebellum—hypothyroidism	0.000633	0.00177	CbGeAlD
Dasatinib—FGR—female gonad—hypothyroidism	0.000633	0.00177	CbGeAlD
Dasatinib—LCK—female gonad—hypothyroidism	0.000633	0.00177	CbGeAlD
Dasatinib—FYN—adrenal gland—hypothyroidism	0.000633	0.00176	CbGeAlD
Dasatinib—FYN—blood—hypothyroidism	0.000633	0.00176	CbGeAlD
Dasatinib—FMO3—thyroid gland—hypothyroidism	0.000633	0.00176	CbGeAlD
Dasatinib—RIPK2—testis—hypothyroidism	0.000632	0.00176	CbGeAlD
Dasatinib—ABL2—liver—hypothyroidism	0.000632	0.00176	CbGeAlD
Dasatinib—SRC—gonad—hypothyroidism	0.00063	0.00176	CbGeAlD
Dasatinib—Diarrhoea—Liotrix—hypothyroidism	0.00063	0.00215	CcSEcCtD
Dasatinib—CSK—cerebellum—hypothyroidism	0.000629	0.00175	CbGeAlD
Dasatinib—CSF1R—cardiovascular system—hypothyroidism	0.000623	0.00174	CbGeAlD
Dasatinib—EPHB4—thyroid gland—hypothyroidism	0.000623	0.00174	CbGeAlD
Dasatinib—JAK2—thyroid gland—hypothyroidism	0.000619	0.00173	CbGeAlD
Dasatinib—MAP4K5—adrenal gland—hypothyroidism	0.000618	0.00172	CbGeAlD
Dasatinib—MAP3K3—adrenal gland—hypothyroidism	0.000618	0.00172	CbGeAlD
Dasatinib—MAP3K3—blood—hypothyroidism	0.000618	0.00172	CbGeAlD
Dasatinib—MAP4K5—blood—hypothyroidism	0.000618	0.00172	CbGeAlD
Dasatinib—SIK1—testis—hypothyroidism	0.000617	0.00172	CbGeAlD
Dasatinib—ABL2—cerebellum—hypothyroidism	0.000617	0.00172	CbGeAlD
Dasatinib—EPHA2—thyroid gland—hypothyroidism	0.000612	0.00171	CbGeAlD
Dasatinib—EPHA4—testis—hypothyroidism	0.000611	0.0017	CbGeAlD
Dasatinib—FYN—thyroid gland—hypothyroidism	0.000611	0.0017	CbGeAlD
Dasatinib—Dizziness—Liotrix—hypothyroidism	0.000609	0.00208	CcSEcCtD
Dasatinib—PDGFRB—adrenal cortex—hypothyroidism	0.000606	0.00169	CbGeAlD
Dasatinib—ERBB3—testis—hypothyroidism	0.000605	0.00169	CbGeAlD
Dasatinib—EPHB4—female gonad—hypothyroidism	0.000602	0.00168	CbGeAlD
Dasatinib—KIT—heart—hypothyroidism	0.0006	0.00167	CbGeAlD
Dasatinib—MAP3K2—testis—hypothyroidism	0.000599	0.00167	CbGeAlD
Dasatinib—JAK2—female gonad—hypothyroidism	0.000598	0.00167	CbGeAlD
Dasatinib—RIPK2—liver—hypothyroidism	0.000598	0.00167	CbGeAlD
Dasatinib—MAP4K5—thyroid gland—hypothyroidism	0.000597	0.00166	CbGeAlD
Dasatinib—MAP3K3—thyroid gland—hypothyroidism	0.000597	0.00166	CbGeAlD
Dasatinib—EPHA2—female gonad—hypothyroidism	0.000591	0.00165	CbGeAlD
Dasatinib—EPHB6—adrenal gland—hypothyroidism	0.000591	0.00165	CbGeAlD
Dasatinib—EPHB6—blood—hypothyroidism	0.000591	0.00165	CbGeAlD
Dasatinib—FYN—female gonad—hypothyroidism	0.00059	0.00165	CbGeAlD
Dasatinib—PDGFRB—heart—hypothyroidism	0.000586	0.00163	CbGeAlD
Dasatinib—Vomiting—Liotrix—hypothyroidism	0.000585	0.002	CcSEcCtD
Dasatinib—RIPK2—cerebellum—hypothyroidism	0.000584	0.00163	CbGeAlD
Dasatinib—SIK1—liver—hypothyroidism	0.000584	0.00163	CbGeAlD
Dasatinib—Rash—Liotrix—hypothyroidism	0.00058	0.00198	CcSEcCtD
Dasatinib—Dermatitis—Liotrix—hypothyroidism	0.00058	0.00198	CcSEcCtD
Dasatinib—MAP4K5—female gonad—hypothyroidism	0.000577	0.00161	CbGeAlD
Dasatinib—MAP3K3—female gonad—hypothyroidism	0.000577	0.00161	CbGeAlD
Dasatinib—Headache—Liotrix—hypothyroidism	0.000577	0.00197	CcSEcCtD
Dasatinib—ERBB3—liver—hypothyroidism	0.000572	0.0016	CbGeAlD
Dasatinib—YES1—adrenal gland—hypothyroidism	0.000571	0.00159	CbGeAlD
Dasatinib—YES1—blood—hypothyroidism	0.000571	0.00159	CbGeAlD
Dasatinib—SIK1—cerebellum—hypothyroidism	0.00057	0.00159	CbGeAlD
Dasatinib—EPHB6—thyroid gland—hypothyroidism	0.00057	0.00159	CbGeAlD
Dasatinib—MAP3K2—liver—hypothyroidism	0.000567	0.00158	CbGeAlD
Dasatinib—KIT—cardiovascular system—hypothyroidism	0.000566	0.00158	CbGeAlD
Dasatinib—CSF1R—gonad—hypothyroidism	0.000566	0.00158	CbGeAlD
Dasatinib—MAP2K5—pituitary gland—hypothyroidism	0.000566	0.00158	CbGeAlD
Dasatinib—EPHA4—cerebellum—hypothyroidism	0.000565	0.00157	CbGeAlD
Dasatinib—MAPK14—testis—hypothyroidism	0.000564	0.00157	CbGeAlD
Dasatinib—LCK—testis—hypothyroidism	0.000561	0.00157	CbGeAlD
Dasatinib—FGR—testis—hypothyroidism	0.000561	0.00157	CbGeAlD
Dasatinib—PDGFRA—adrenal gland—hypothyroidism	0.00056	0.00156	CbGeAlD
Dasatinib—PDGFRA—blood—hypothyroidism	0.00056	0.00156	CbGeAlD
Dasatinib—ERBB3—cerebellum—hypothyroidism	0.000559	0.00156	CbGeAlD
Dasatinib—MAP3K2—cerebellum—hypothyroidism	0.000554	0.00154	CbGeAlD
Dasatinib—PDGFRB—cardiovascular system—hypothyroidism	0.000553	0.00154	CbGeAlD
Dasatinib—CSF1R—pituitary gland—hypothyroidism	0.000552	0.00154	CbGeAlD
Dasatinib—YES1—thyroid gland—hypothyroidism	0.000551	0.00154	CbGeAlD
Dasatinib—EPHB6—female gonad—hypothyroidism	0.000551	0.00154	CbGeAlD
Dasatinib—SRC—adrenal gland—hypothyroidism	0.000549	0.00153	CbGeAlD
Dasatinib—SRC—blood—hypothyroidism	0.000549	0.00153	CbGeAlD
Dasatinib—Nausea—Liotrix—hypothyroidism	0.000547	0.00187	CcSEcCtD
Dasatinib—FMO3—testis—hypothyroidism	0.000542	0.00151	CbGeAlD
Dasatinib—PDGFRA—thyroid gland—hypothyroidism	0.000541	0.00151	CbGeAlD
Dasatinib—ABL1—adrenal cortex—hypothyroidism	0.00054	0.00151	CbGeAlD
Dasatinib—EPHB4—testis—hypothyroidism	0.000534	0.00149	CbGeAlD
Dasatinib—MAPK14—liver—hypothyroidism	0.000533	0.00149	CbGeAlD
Dasatinib—YES1—female gonad—hypothyroidism	0.000532	0.00148	CbGeAlD
Dasatinib—LCK—liver—hypothyroidism	0.000531	0.00148	CbGeAlD
Dasatinib—FGR—liver—hypothyroidism	0.000531	0.00148	CbGeAlD
Dasatinib—JAK2—testis—hypothyroidism	0.000531	0.00148	CbGeAlD
Dasatinib—SRC—thyroid gland—hypothyroidism	0.00053	0.00148	CbGeAlD
Dasatinib—EPHA2—testis—hypothyroidism	0.000524	0.00146	CbGeAlD
Dasatinib—FYN—testis—hypothyroidism	0.000523	0.00146	CbGeAlD
Dasatinib—PDGFRA—female gonad—hypothyroidism	0.000522	0.00146	CbGeAlD
Dasatinib—ABL1—heart—hypothyroidism	0.000522	0.00146	CbGeAlD
Dasatinib—MAPK14—cerebellum—hypothyroidism	0.000521	0.00145	CbGeAlD
Dasatinib—KIT—gonad—hypothyroidism	0.000514	0.00143	CbGeAlD
Dasatinib—FMO3—liver—hypothyroidism	0.000513	0.00143	CbGeAlD
Dasatinib—SRC—female gonad—hypothyroidism	0.000512	0.00143	CbGeAlD
Dasatinib—MAP3K3—testis—hypothyroidism	0.000511	0.00143	CbGeAlD
Dasatinib—MAP4K5—testis—hypothyroidism	0.000511	0.00143	CbGeAlD
Dasatinib—MAP2K5—adrenal gland—hypothyroidism	0.000505	0.00141	CbGeAlD
Dasatinib—MAP2K5—blood—hypothyroidism	0.000505	0.00141	CbGeAlD
Dasatinib—EPHB4—liver—hypothyroidism	0.000505	0.00141	CbGeAlD
Dasatinib—PDGFRB—gonad—hypothyroidism	0.000502	0.0014	CbGeAlD
Dasatinib—JAK2—liver—hypothyroidism	0.000502	0.0014	CbGeAlD
Dasatinib—KIT—pituitary gland—hypothyroidism	0.000501	0.0014	CbGeAlD
Dasatinib—EPHA2—liver—hypothyroidism	0.000496	0.00138	CbGeAlD
Dasatinib—FYN—liver—hypothyroidism	0.000495	0.00138	CbGeAlD
Dasatinib—EPHB4—cerebellum—hypothyroidism	0.000493	0.00138	CbGeAlD
Dasatinib—CSF1R—adrenal gland—hypothyroidism	0.000493	0.00138	CbGeAlD
Dasatinib—CSF1R—blood—hypothyroidism	0.000493	0.00138	CbGeAlD
Dasatinib—ABL1—cardiovascular system—hypothyroidism	0.000493	0.00137	CbGeAlD
Dasatinib—JAK2—cerebellum—hypothyroidism	0.00049	0.00137	CbGeAlD
Dasatinib—PDGFRB—pituitary gland—hypothyroidism	0.00049	0.00137	CbGeAlD
Dasatinib—EPHB6—testis—hypothyroidism	0.000489	0.00136	CbGeAlD
Dasatinib—MAP2K5—thyroid gland—hypothyroidism	0.000488	0.00136	CbGeAlD
Dasatinib—MAP3K3—liver—hypothyroidism	0.000483	0.00135	CbGeAlD
Dasatinib—MAP4K5—liver—hypothyroidism	0.000483	0.00135	CbGeAlD
Dasatinib—FYN—cerebellum—hypothyroidism	0.000483	0.00135	CbGeAlD
Dasatinib—CSF1R—thyroid gland—hypothyroidism	0.000476	0.00133	CbGeAlD
Dasatinib—MAP3K3—cerebellum—hypothyroidism	0.000472	0.00132	CbGeAlD
Dasatinib—MAP4K5—cerebellum—hypothyroidism	0.000472	0.00132	CbGeAlD
Dasatinib—YES1—testis—hypothyroidism	0.000472	0.00132	CbGeAlD
Dasatinib—MAP2K5—female gonad—hypothyroidism	0.000471	0.00131	CbGeAlD
Dasatinib—PDGFRA—testis—hypothyroidism	0.000463	0.00129	CbGeAlD
Dasatinib—CSF1R—female gonad—hypothyroidism	0.00046	0.00128	CbGeAlD
Dasatinib—SRC—testis—hypothyroidism	0.000454	0.00127	CbGeAlD
Dasatinib—EPHB6—cerebellum—hypothyroidism	0.000451	0.00126	CbGeAlD
Dasatinib—KIT—adrenal gland—hypothyroidism	0.000448	0.00125	CbGeAlD
Dasatinib—KIT—blood—hypothyroidism	0.000448	0.00125	CbGeAlD
Dasatinib—ABL1—gonad—hypothyroidism	0.000447	0.00125	CbGeAlD
Dasatinib—YES1—liver—hypothyroidism	0.000446	0.00125	CbGeAlD
Dasatinib—CYP1B1—heart—hypothyroidism	0.000442	0.00123	CbGeAlD
Dasatinib—PDGFRA—liver—hypothyroidism	0.000438	0.00122	CbGeAlD
Dasatinib—PDGFRB—adrenal gland—hypothyroidism	0.000437	0.00122	CbGeAlD
Dasatinib—PDGFRB—blood—hypothyroidism	0.000437	0.00122	CbGeAlD
Dasatinib—ABL1—pituitary gland—hypothyroidism	0.000436	0.00122	CbGeAlD
Dasatinib—YES1—cerebellum—hypothyroidism	0.000436	0.00122	CbGeAlD
Dasatinib—KIT—thyroid gland—hypothyroidism	0.000432	0.00121	CbGeAlD
Dasatinib—SRC—liver—hypothyroidism	0.000429	0.0012	CbGeAlD
Dasatinib—PDGFRA—cerebellum—hypothyroidism	0.000428	0.00119	CbGeAlD
Dasatinib—PDGFRB—thyroid gland—hypothyroidism	0.000422	0.00118	CbGeAlD
Dasatinib—SRC—cerebellum—hypothyroidism	0.00042	0.00117	CbGeAlD
Dasatinib—MAP2K5—testis—hypothyroidism	0.000418	0.00117	CbGeAlD
Dasatinib—KIT—female gonad—hypothyroidism	0.000418	0.00116	CbGeAlD
Dasatinib—CYP1B1—cardiovascular system—hypothyroidism	0.000417	0.00116	CbGeAlD
Dasatinib—CSF1R—testis—hypothyroidism	0.000408	0.00114	CbGeAlD
Dasatinib—PDGFRB—female gonad—hypothyroidism	0.000408	0.00114	CbGeAlD
Dasatinib—MAP2K5—liver—hypothyroidism	0.000395	0.0011	CbGeAlD
Dasatinib—ABL1—adrenal gland—hypothyroidism	0.00039	0.00109	CbGeAlD
Dasatinib—ABL1—blood—hypothyroidism	0.00039	0.00109	CbGeAlD
Dasatinib—MAP2K5—cerebellum—hypothyroidism	0.000386	0.00108	CbGeAlD
Dasatinib—CSF1R—liver—hypothyroidism	0.000386	0.00108	CbGeAlD
Dasatinib—CYP1B1—gonad—hypothyroidism	0.000379	0.00106	CbGeAlD
Dasatinib—CSF1R—cerebellum—hypothyroidism	0.000377	0.00105	CbGeAlD
Dasatinib—ABL1—thyroid gland—hypothyroidism	0.000376	0.00105	CbGeAlD
Dasatinib—KIT—testis—hypothyroidism	0.00037	0.00103	CbGeAlD
Dasatinib—CYP1B1—pituitary gland—hypothyroidism	0.00037	0.00103	CbGeAlD
Dasatinib—ABL1—female gonad—hypothyroidism	0.000363	0.00101	CbGeAlD
Dasatinib—PDGFRB—testis—hypothyroidism	0.000362	0.00101	CbGeAlD
Dasatinib—KIT—liver—hypothyroidism	0.00035	0.000977	CbGeAlD
Dasatinib—KIT—cerebellum—hypothyroidism	0.000342	0.000954	CbGeAlD
Dasatinib—PDGFRB—liver—hypothyroidism	0.000342	0.000954	CbGeAlD
Dasatinib—ABCG2—adrenal cortex—hypothyroidism	0.000341	0.00095	CbGeAlD
Dasatinib—PDGFRB—cerebellum—hypothyroidism	0.000334	0.000932	CbGeAlD
Dasatinib—CYP1B1—adrenal gland—hypothyroidism	0.00033	0.000921	CbGeAlD
Dasatinib—CYP1B1—blood—hypothyroidism	0.00033	0.000921	CbGeAlD
Dasatinib—ABCG2—heart—hypothyroidism	0.000329	0.000919	CbGeAlD
Dasatinib—ABL1—testis—hypothyroidism	0.000322	0.000899	CbGeAlD
Dasatinib—CYP1B1—thyroid gland—hypothyroidism	0.000319	0.000889	CbGeAlD
Dasatinib—CYP1A1—heart—hypothyroidism	0.000313	0.000872	CbGeAlD
Dasatinib—CYP1B1—female gonad—hypothyroidism	0.000308	0.000859	CbGeAlD
Dasatinib—ABL1—liver—hypothyroidism	0.000305	0.00085	CbGeAlD
Dasatinib—ABL1—cerebellum—hypothyroidism	0.000298	0.00083	CbGeAlD
Dasatinib—ABCG2—pituitary gland—hypothyroidism	0.000275	0.000768	CbGeAlD
Dasatinib—CYP1B1—testis—hypothyroidism	0.000273	0.000761	CbGeAlD
Dasatinib—CYP1B1—liver—hypothyroidism	0.000258	0.00072	CbGeAlD
Dasatinib—CYP1B1—cerebellum—hypothyroidism	0.000252	0.000703	CbGeAlD
Dasatinib—ABCG2—adrenal gland—hypothyroidism	0.000246	0.000686	CbGeAlD
Dasatinib—ABCG2—blood—hypothyroidism	0.000246	0.000686	CbGeAlD
Dasatinib—ABCG2—thyroid gland—hypothyroidism	0.000237	0.000662	CbGeAlD
Dasatinib—CYP1A2—blood—hypothyroidism	0.000237	0.00066	CbGeAlD
Dasatinib—CYP1A1—blood—hypothyroidism	0.000233	0.000651	CbGeAlD
Dasatinib—ABCG2—female gonad—hypothyroidism	0.000229	0.000639	CbGeAlD
Dasatinib—CYP1A2—thyroid gland—hypothyroidism	0.000228	0.000637	CbGeAlD
Dasatinib—CYP3A5—blood—hypothyroidism	0.000228	0.000636	CbGeAlD
Dasatinib—CYP1A1—thyroid gland—hypothyroidism	0.000225	0.000628	CbGeAlD
Dasatinib—CYP1A1—female gonad—hypothyroidism	0.000218	0.000607	CbGeAlD
Dasatinib—CYP3A5—female gonad—hypothyroidism	0.000213	0.000593	CbGeAlD
Dasatinib—ABCG2—testis—hypothyroidism	0.000203	0.000567	CbGeAlD
Dasatinib—ABCG2—liver—hypothyroidism	0.000192	0.000536	CbGeAlD
Dasatinib—ABCG2—cerebellum—hypothyroidism	0.000188	0.000524	CbGeAlD
Dasatinib—CYP1A2—liver—hypothyroidism	0.000185	0.000516	CbGeAlD
Dasatinib—CYP1A1—liver—hypothyroidism	0.000182	0.000509	CbGeAlD
Dasatinib—CYP3A5—liver—hypothyroidism	0.000178	0.000498	CbGeAlD
Dasatinib—CYP3A4—blood—hypothyroidism	0.000171	0.000478	CbGeAlD
Dasatinib—ABCB1—adrenal cortex—hypothyroidism	0.000168	0.000468	CbGeAlD
Dasatinib—ABCB1—heart—hypothyroidism	0.000162	0.000453	CbGeAlD
Dasatinib—ABCB1—cardiovascular system—hypothyroidism	0.000153	0.000427	CbGeAlD
Dasatinib—ABCB1—gonad—hypothyroidism	0.000139	0.000388	CbGeAlD
Dasatinib—ABCB1—pituitary gland—hypothyroidism	0.000136	0.000378	CbGeAlD
Dasatinib—CYP3A4—liver—hypothyroidism	0.000134	0.000373	CbGeAlD
Dasatinib—ABCB1—adrenal gland—hypothyroidism	0.000121	0.000338	CbGeAlD
Dasatinib—ABCB1—blood—hypothyroidism	0.000121	0.000338	CbGeAlD
Dasatinib—ABCB1—thyroid gland—hypothyroidism	0.000117	0.000326	CbGeAlD
Dasatinib—ABCB1—female gonad—hypothyroidism	0.000113	0.000315	CbGeAlD
Dasatinib—ABCB1—testis—hypothyroidism	0.0001	0.00028	CbGeAlD
Dasatinib—ABCB1—liver—hypothyroidism	9.48e-05	0.000264	CbGeAlD
Dasatinib—ABCB1—cerebellum—hypothyroidism	9.26e-05	0.000258	CbGeAlD
Dasatinib—FYN—Innate Immune System—VAV3—hypothyroidism	5.39e-05	0.00019	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—PRL—hypothyroidism	5.34e-05	0.000188	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TSHB—hypothyroidism	5.34e-05	0.000188	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TSHR—hypothyroidism	5.34e-05	0.000188	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—TSHR—hypothyroidism	5.33e-05	0.000188	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—TSHB—hypothyroidism	5.33e-05	0.000188	CbGpPWpGaD
Dasatinib—BLK—Immune System—VAV3—hypothyroidism	5.31e-05	0.000187	CbGpPWpGaD
Dasatinib—FGR—Immune System—VAV3—hypothyroidism	5.29e-05	0.000187	CbGpPWpGaD
Dasatinib—SRC—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	5.27e-05	0.000186	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ATP5O—hypothyroidism	5.26e-05	0.000186	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—PRL—hypothyroidism	5.26e-05	0.000186	CbGpPWpGaD
Dasatinib—CYP3A5—Biological oxidations—POMC—hypothyroidism	5.25e-05	0.000185	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CLTC—hypothyroidism	5.24e-05	0.000185	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—SH2B3—hypothyroidism	5.2e-05	0.000183	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—VAV3—hypothyroidism	5.19e-05	0.000183	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—PRL—hypothyroidism	5.17e-05	0.000182	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TSHB—hypothyroidism	5.14e-05	0.000181	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TSHR—hypothyroidism	5.14e-05	0.000181	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—VAV3—hypothyroidism	5.12e-05	0.000181	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.11e-05	0.00018	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TRH—hypothyroidism	5.07e-05	0.000179	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—IGF1—hypothyroidism	5.02e-05	0.000177	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—VAV3—hypothyroidism	4.98e-05	0.000176	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ATP5O—hypothyroidism	4.97e-05	0.000175	CbGpPWpGaD
Dasatinib—CYP1A1—Biological oxidations—POMC—hypothyroidism	4.96e-05	0.000175	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CLTC—hypothyroidism	4.96e-05	0.000175	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—TPO—hypothyroidism	4.95e-05	0.000175	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—VAV3—hypothyroidism	4.94e-05	0.000174	CbGpPWpGaD
Dasatinib—SRC—Immune System—CLTC—hypothyroidism	4.91e-05	0.000173	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—VAV3—hypothyroidism	4.87e-05	0.000172	CbGpPWpGaD
Dasatinib—ERBB3—Disease—PRL—hypothyroidism	4.86e-05	0.000171	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—VAV3—hypothyroidism	4.78e-05	0.000169	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—AVP—hypothyroidism	4.76e-05	0.000168	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—SH2B3—hypothyroidism	4.76e-05	0.000168	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—TPO—hypothyroidism	4.68e-05	0.000165	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—IYD—hypothyroidism	4.67e-05	0.000165	CbGpPWpGaD
Dasatinib—YES1—Immune System—PRL—hypothyroidism	4.62e-05	0.000163	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—AVP—hypothyroidism	4.61e-05	0.000162	CbGpPWpGaD
Dasatinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.59e-05	0.000162	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—SH2B3—hypothyroidism	4.59e-05	0.000162	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TRH—hypothyroidism	4.52e-05	0.00016	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TSHB—hypothyroidism	4.52e-05	0.000159	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TSHR—hypothyroidism	4.52e-05	0.000159	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—VAV3—hypothyroidism	4.49e-05	0.000158	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—POMC—hypothyroidism	4.49e-05	0.000158	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—VAV3—hypothyroidism	4.48e-05	0.000158	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CLTC—hypothyroidism	4.46e-05	0.000157	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—VAV3—hypothyroidism	4.41e-05	0.000155	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CLTC—hypothyroidism	4.37e-05	0.000154	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.33e-05	0.000153	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—IGF1—hypothyroidism	4.32e-05	0.000152	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CLTC—hypothyroidism	4.3e-05	0.000152	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TRH—hypothyroidism	4.28e-05	0.000151	CbGpPWpGaD
Dasatinib—YES1—Immune System—VAV3—hypothyroidism	4.27e-05	0.000151	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CLTC—hypothyroidism	4.14e-05	0.000146	CbGpPWpGaD
Dasatinib—KIT—Immune System—PRL—hypothyroidism	4.12e-05	0.000145	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CLTC—hypothyroidism	4.09e-05	0.000144	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TSHB—hypothyroidism	4.03e-05	0.000142	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TSHR—hypothyroidism	4.03e-05	0.000142	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—SH2B3—hypothyroidism	4.02e-05	0.000142	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.02e-05	0.000142	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ATP5O—hypothyroidism	3.97e-05	0.00014	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—VAV3—hypothyroidism	3.97e-05	0.00014	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—PRL—hypothyroidism	3.9e-05	0.000138	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—PRL—hypothyroidism	3.86e-05	0.000136	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TRH—hypothyroidism	3.86e-05	0.000136	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TSHB—hypothyroidism	3.82e-05	0.000135	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TSHR—hypothyroidism	3.82e-05	0.000135	CbGpPWpGaD
Dasatinib—KIT—Immune System—VAV3—hypothyroidism	3.82e-05	0.000135	CbGpPWpGaD
Dasatinib—KIT—Disease—PRL—hypothyroidism	3.81e-05	0.000134	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TRH—hypothyroidism	3.78e-05	0.000133	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—IGF1—hypothyroidism	3.74e-05	0.000132	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—TPO—hypothyroidism	3.73e-05	0.000132	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—IYD—hypothyroidism	3.73e-05	0.000131	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—IGF1—hypothyroidism	3.72e-05	0.000131	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TRH—hypothyroidism	3.72e-05	0.000131	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—IGF1—hypothyroidism	3.68e-05	0.00013	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—VAV3—hypothyroidism	3.61e-05	0.000127	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—PRL—hypothyroidism	3.6e-05	0.000127	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—SH2B3—hypothyroidism	3.59e-05	0.000127	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—VAV3—hypothyroidism	3.59e-05	0.000127	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CLTC—hypothyroidism	3.58e-05	0.000126	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TRH—hypothyroidism	3.58e-05	0.000126	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—VAV3—hypothyroidism	3.57e-05	0.000126	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—IGF1—hypothyroidism	3.55e-05	0.000125	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TRH—hypothyroidism	3.54e-05	0.000125	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—PRL—hypothyroidism	3.53e-05	0.000124	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—PRL—hypothyroidism	3.52e-05	0.000124	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—TSHB—hypothyroidism	3.51e-05	0.000124	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.5e-05	0.000123	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—IGF1—hypothyroidism	3.5e-05	0.000123	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—AVP—hypothyroidism	3.46e-05	0.000122	CbGpPWpGaD
Dasatinib—LYN—Immune System—PRL—hypothyroidism	3.44e-05	0.000121	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AVP—hypothyroidism	3.44e-05	0.000121	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TSHR—hypothyroidism	3.44e-05	0.000121	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TSHB—hypothyroidism	3.44e-05	0.000121	CbGpPWpGaD
Dasatinib—ABL1—Immune System—PRL—hypothyroidism	3.43e-05	0.000121	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—SH2B3—hypothyroidism	3.4e-05	0.00012	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—PRL—hypothyroidism	3.4e-05	0.00012	CbGpPWpGaD
Dasatinib—FYN—Immune System—PRL—hypothyroidism	3.39e-05	0.00012	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TSHB—hypothyroidism	3.37e-05	0.000119	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TSHR—hypothyroidism	3.37e-05	0.000119	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TSHR—hypothyroidism	3.31e-05	0.000117	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TSHB—hypothyroidism	3.31e-05	0.000117	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—VAV3—hypothyroidism	3.26e-05	0.000115	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—PRL—hypothyroidism	3.26e-05	0.000115	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—VAV3—hypothyroidism	3.26e-05	0.000115	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—VAV3—hypothyroidism	3.25e-05	0.000115	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—PRL—hypothyroidism	3.25e-05	0.000115	CbGpPWpGaD
Dasatinib—JAK2—Immune System—PRL—hypothyroidism	3.22e-05	0.000114	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—TSHB—hypothyroidism	3.2e-05	0.000113	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TSHB—hypothyroidism	3.19e-05	0.000113	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TSHR—hypothyroidism	3.19e-05	0.000113	CbGpPWpGaD
Dasatinib—LYN—Immune System—VAV3—hypothyroidism	3.19e-05	0.000112	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CLTC—hypothyroidism	3.17e-05	0.000112	CbGpPWpGaD
Dasatinib—ABL1—Immune System—VAV3—hypothyroidism	3.17e-05	0.000112	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ATP5O—hypothyroidism	3.17e-05	0.000112	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—POMC—hypothyroidism	3.16e-05	0.000111	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—POMC—hypothyroidism	3.16e-05	0.000111	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TSHR—hypothyroidism	3.15e-05	0.000111	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TSHB—hypothyroidism	3.15e-05	0.000111	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—VAV3—hypothyroidism	3.15e-05	0.000111	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AVP—hypothyroidism	3.15e-05	0.000111	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AVP—hypothyroidism	3.14e-05	0.000111	CbGpPWpGaD
Dasatinib—FYN—Immune System—VAV3—hypothyroidism	3.14e-05	0.000111	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PIK3C2A—hypothyroidism	3.13e-05	0.00011	CbGpPWpGaD
Dasatinib—FYN—Disease—PRL—hypothyroidism	3.13e-05	0.00011	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TRH—hypothyroidism	3.1e-05	0.000109	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.09e-05	0.000109	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—IGF1—hypothyroidism	3.07e-05	0.000108	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—POMC—hypothyroidism	3.07e-05	0.000108	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SH2B3—hypothyroidism	3.07e-05	0.000108	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—POMC—hypothyroidism	3.06e-05	0.000108	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IGF1—hypothyroidism	3.04e-05	0.000107	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AVP—hypothyroidism	3.03e-05	0.000107	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—VAV3—hypothyroidism	3.02e-05	0.000106	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SH2B3—hypothyroidism	3e-05	0.000106	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PRL—hypothyroidism	2.99e-05	0.000105	CbGpPWpGaD
Dasatinib—JAK2—Immune System—VAV3—hypothyroidism	2.98e-05	0.000105	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TPO—hypothyroidism	2.98e-05	0.000105	CbGpPWpGaD
Dasatinib—JAK2—Disease—PRL—hypothyroidism	2.98e-05	0.000105	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SH2B3—hypothyroidism	2.95e-05	0.000104	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IGF1—hypothyroidism	2.94e-05	0.000104	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—IYD—hypothyroidism	2.88e-05	0.000101	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	2.85e-05	0.0001	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SH2B3—hypothyroidism	2.85e-05	0.0001	CbGpPWpGaD
Dasatinib—LCK—Immune System—PRL—hypothyroidism	2.82e-05	9.95e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SH2B3—hypothyroidism	2.81e-05	9.9e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.76e-05	9.74e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VAV3—hypothyroidism	2.76e-05	9.74e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.76e-05	9.74e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TSHB—hypothyroidism	2.76e-05	9.73e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TSHR—hypothyroidism	2.76e-05	9.73e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TRH—hypothyroidism	2.74e-05	9.67e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—IGF1—hypothyroidism	2.72e-05	9.57e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PRL—hypothyroidism	2.67e-05	9.4e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AVP—hypothyroidism	2.66e-05	9.39e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—SLC5A5—hypothyroidism	2.63e-05	9.28e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—VAV3—hypothyroidism	2.61e-05	9.21e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PRL—hypothyroidism	2.61e-05	9.19e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PRL—hypothyroidism	2.52e-05	8.9e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—PRL—hypothyroidism	2.5e-05	8.81e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VAV3—hypothyroidism	2.47e-05	8.7e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SH2B3—hypothyroidism	2.46e-05	8.67e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.45e-05	8.63e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TSHB—hypothyroidism	2.44e-05	8.62e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TSHR—hypothyroidism	2.44e-05	8.62e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.44e-05	8.6e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—SLC5A5—hypothyroidism	2.39e-05	8.44e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AVP—hypothyroidism	2.38e-05	8.38e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VAV3—hypothyroidism	2.34e-05	8.23e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—VAV3—hypothyroidism	2.31e-05	8.15e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—PRL—hypothyroidism	2.31e-05	8.14e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TPO—hypothyroidism	2.3e-05	8.11e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—POMC—hypothyroidism	2.3e-05	8.11e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—TSHB—hypothyroidism	2.29e-05	8.08e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—POMC—hypothyroidism	2.29e-05	8.06e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PRL—hypothyroidism	2.27e-05	8.02e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AVP—hypothyroidism	2.25e-05	7.93e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PRL—hypothyroidism	2.23e-05	7.85e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IGF1—hypothyroidism	2.2e-05	7.75e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PRL—hypothyroidism	2.19e-05	7.73e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SH2B3—hypothyroidism	2.18e-05	7.68e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.18e-05	7.67e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—TSHB—hypothyroidism	2.16e-05	7.63e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PRL—hypothyroidism	2.11e-05	7.44e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VAV3—hypothyroidism	2.1e-05	7.42e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—POMC—hypothyroidism	2.09e-05	7.37e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—POMC—hypothyroidism	2.09e-05	7.37e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PRL—hypothyroidism	2.08e-05	7.35e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VAV3—hypothyroidism	2.06e-05	7.26e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	2.04e-05	7.2e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VAV3—hypothyroidism	2.03e-05	7.15e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AVP—hypothyroidism	2.03e-05	7.15e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—POMC—hypothyroidism	2.01e-05	7.1e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IGF1—hypothyroidism	2.01e-05	7.09e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AVP—hypothyroidism	1.98e-05	7e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AVP—hypothyroidism	1.95e-05	6.89e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VAV3—hypothyroidism	1.95e-05	6.89e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IGF1—hypothyroidism	1.94e-05	6.83e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	1.93e-05	6.8e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VAV3—hypothyroidism	1.93e-05	6.8e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.9e-05	6.71e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AVP—hypothyroidism	1.88e-05	6.63e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AVP—hypothyroidism	1.86e-05	6.55e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PRL—hypothyroidism	1.82e-05	6.44e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—POMC—hypothyroidism	1.77e-05	6.24e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—TSHB—hypothyroidism	1.73e-05	6.1e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.71e-05	6.05e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IGF1—hypothyroidism	1.7e-05	6e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VAV3—hypothyroidism	1.69e-05	5.95e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AVP—hypothyroidism	1.63e-05	5.74e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SLC5A5—hypothyroidism	1.62e-05	5.71e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PRL—hypothyroidism	1.62e-05	5.7e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—POMC—hypothyroidism	1.58e-05	5.57e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.54e-05	5.43e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IGF1—hypothyroidism	1.52e-05	5.36e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—POMC—hypothyroidism	1.5e-05	5.27e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VAV3—hypothyroidism	1.49e-05	5.27e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AVP—hypothyroidism	1.44e-05	5.08e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IGF1—hypothyroidism	1.44e-05	5.07e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—TSHB—hypothyroidism	1.38e-05	4.87e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—POMC—hypothyroidism	1.38e-05	4.85e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—POMC—hypothyroidism	1.35e-05	4.75e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—POMC—hypothyroidism	1.32e-05	4.65e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—hypothyroidism	1.3e-05	4.58e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IGF1—hypothyroidism	1.3e-05	4.57e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.29e-05	4.56e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IGF1—hypothyroidism	1.27e-05	4.47e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—hypothyroidism	1.25e-05	4.42e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—hypothyroidism	1.25e-05	4.41e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IGF1—hypothyroidism	1.25e-05	4.4e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—hypothyroidism	1.23e-05	4.35e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.23e-05	4.34e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.21e-05	4.28e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IGF1—hypothyroidism	1.2e-05	4.24e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IGF1—hypothyroidism	1.19e-05	4.19e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—hypothyroidism	1.08e-05	3.81e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TSHB—hypothyroidism	1.07e-05	3.76e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IGF1—hypothyroidism	1.04e-05	3.67e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.03e-05	3.64e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—hypothyroidism	9.57e-06	3.37e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	9.49e-06	3.35e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IGF1—hypothyroidism	9.2e-06	3.25e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—hypothyroidism	8.97e-06	3.16e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—hypothyroidism	8.48e-06	2.99e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.97e-06	2.81e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—hypothyroidism	6.77e-06	2.39e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—hypothyroidism	5.41e-06	1.91e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—hypothyroidism	4.17e-06	1.47e-05	CbGpPWpGaD
